References
- Colombo P, Bettini R, Santi P, Peppas NA. (2000). Swellable matrices for controlled drug delivery: gel-layer behaviour, mechanisms and optimal performance. Pharm Sci Technol Today, 3:198–204.
- Kranz H, Guthmann C, Wagner T, Lipp R, Reinhard J. (2005). Development of a single unit extended release formulation for ZK 811 752, a weakly basic drug. Eur J Pharm Sci, 26:47–53.
- Fukuda M, Peppas NA, McGinity JW. (2006). Properties of sustained release hot-melt extruded tablets containing chitosan and xanthan gum. Int J Pharm, 310:90–100.
- Bonferoni MC, Rossi S, Ferrari F, Bertoni M, Bolhuis GK, Caramella C. (1998). On the employment of lambda carrageenan in a matrix system. III. Optimization of a lambda carrageenan-HPMC hydrophilic matrix. J Control Release, 51:231–239.
- Huang YB, Tsai YH, Lee SH, Chang JS, Wu PC. (2005). Optimization of pH-independent release of nicardipine hydrochloride extended-release matrix tablets using response surface methodology. Int J Pharm, 289:87–95.
- Alkhatib HS, Aiedeh KM, Bustanji Y, Hamed S, Mohammad MK, Alkhalidi B,NajjarS (2008). Modulation of buspirone HCl release from hypromellose matrices using chitosan succinate: implications for pH-independent release. Eur J Pharm Biopharm, 70:804–812.
- Singla M, Chawla A, Singh A. (2000). Potential applications of Carbomer in oral mucoadhesive controlled drug delivery system: a review. Drug Dev Ind Pharm, 26:913–924.
- Shilpa A, Agrawal S, Ray A. (2003). Controlled delivery of drugs from alginate matrix. J Macromol Sci Polym Rev, C43:187–221.
- Parojcic J, Ethuric Z, Jovanovic M, Ibric S, Jovanovic D. (2004). Influence of dissolution media composition on drug release and in-vitro/in-vivo correlation for paracetamol matrix tablets prepared with novel carbomer polymers. J Pharm Pharmacol, 56:735–741.
- Ravi PR, Kotreka UK, Saha RN. (2008). Controlled release matrix tablets of zidovudine: effect of formulation variables on the in vitro drug release kinetics. AAPS PharmsciTech, 9:302–313.
- Wahlgren M, Christensen KL, Jørgensen EV, Svensson A, Ulvenlund S. (2009). Oral-based controlled release formulations using poly(acrylic acid) microgels. Drug Dev Ind Pharm, 35:922–929.
- Tapia-Albarran M, Villafuerte-Robles L. (2004). Effect of formulation and process variables on the release behavior of amoxicillin matrix tablets. Drug Dev Ind Pharm, 30:901–908.
- Xiaoqiang X, Minjie S, Feng Z, Yiqiao H. (2006). Floating matrix dosage form for phenoporlamine hydrochloride based on gas forming agent: In vitro and in vivo evaluation in healthy volunteers. Int J Pharm, 310:139–145.
- Adhikary A, Vavia PR. (2008). Bioadhesive ranitidine hydrochloride for gastroretention with controlled microenvironmental pH. Drug Dev Ind Pharm, 34:860–869.
- Gutiérrez-Sánchez PE, Hernández-León A, Villafuerte-Robles L. (2008). Effect of sodium bicarbonate on the properties of metronidazole floating matrix tablets. Drug Dev Ind Pharm, 34:171–180.
- Efentakis M, Buckton G. (2002). The effect of erosion and swelling on the dissolution of theophylline from low and high viscosity sodium alginate matrices. Pharm Dev Technol, 7:69–77.
- Liew CV, Chan LW, Ching AL, Heng PW. (2006). Evaluation of sodium alginate as drug release modifier in matrix tablets. Int J Pharm, 309:25–37.
- Broadhead J, Edmond Rouan SK, Rhodes CT. (1992). The spray drying of pharmaceuticals. Drug Dev Ind Pharm, 18:1169–1206.
- Pringels E, Ameye D, Vervaet C, Foreman P, Remon JP. (2005). Starch/Carbopol spray-dried mixtures as excipients for oral sustained drug delivery. J Control Release, 103:635–641.
- Dürig T, Fassihi R. (2000). Evaluation of floating and sticking extended release delivery systems: an unconventional dissolution test. J Control Release, 67:37–44.
- Peppas NA. (1985). Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv, 60:110–111.
- Ritger PL, Peppas NA. (1987). A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices. J Control Release, 5:37–42.
- Giunchedi P, Gavini E, Bonacucina G, Palmieri GF. (2000). Tabletted polylactide microspheres prepared by a w/o emulsion–spray drying method. J Microencapsul, 17:711–720.
- Takeuchi H, Yasuji T, Hino T, Yamamoto H, Kawashima Y. (1998). Spray-dried composite particles of lactose and sodium alginate for direct tabletting and controlled releasing. Int J Pharm, 174:91–100.
- Hodsdon A, Mitchell J, Davies M, Melia C. (1995). Structure and behavior in hydrophilic matrix sustained release dosage forms. 3. The influence of pH on the sustained-release performance and internal gel structure of sodium alginate matrices. J Control Release, 33:143–152.
- Lubrizol. (2008). Formulating Controlled Release Tablets and Capsules with Carbopol® Polymers. Pharmaceutical Bulletin No. 31.
- Moore J, Flanner H. (1996). Mathematical comparison of curves with an emphasis on in-vitro dissolution profiles. Pharm Technol, 20:64–74.
- FDA. (1997). Guidance for Industry: Dissolution Testing of Immediate Release Solid Oral Dosage Forms. Center for Drug Evaluation and Research, Rockville, MD.
- Gutsche S, Krause M, Kranz H. (2008). Strategies to overcome pH-dependent solubility of weakly basic drugs by using different types of alginates. Drug Dev Ind Pharm, 34:1277–1284
- FMC BioPolymer. (2003). Technical Information for Protanal. Philadelphia, USA.
- Sriamornsak P, Thirawong N, Korkerd K. (2007a). Swelling, erosion and release behavior of alginate-based matrix tablets. Eur J Pharm Biopharm, 66:435–450.
- Sriamornsak P, Thirawong N, Weerapol Y, Nunthanid J, Sungthongjeen S. (2007b). Swelling and erosion of pectin matrix tablets and their impact on drug release behavior. Eur J Pharm Biopharm, 67:211–219.
- Sujja-areevath J, Munday DL, Cox PJ, Khan KA. (1998). Relationship between swelling, erosion and drug release in hydrophilic natural gum mini-matrix formulations. Eur J Pharm Sci, 6:207–217.
- Rawlings J, Pantula S, Dickey D. (1998). Applied Regression Analysis. A Research Tool, Second Edition. New York: Springer-Verlag.